Monitoring of urinary L-type fatty acid-binding protein predicts histological severity of acute kidney injury

American Journal of Pathology

Volumn 174, Issue 4, 2009, Pages 1154-1159

  Negishi, Kousuke ^a   Noiri, Eisei ^a   Doi, Kent ^a   Maeda Mamiya, Rui ^a   Sugaya, Takeshi ^b   Portilla, Didier ^c,d   Fujita, Toshiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Strategic and Regulatory Affairs Consulting Department   (Japan)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLGLUCOSAMINIDASE; CISPLATIN; FATTY ACID BINDING PROTEIN; FLUORESCEIN ISOTHIOCYANATE; INULIN; L TYPE FATTY ACID BINDING PROTEIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CROSS LINKING REAGENT; FABP1 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; GLOMERULUS FILTRATION RATE; HISTOLOGY; INTERMETHOD COMPARISON; ISCHEMIA; KIDNEY; KIDNEY INJURY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN URINE LEVEL; REPERFUSION INJURY; TRANSGENIC MOUSE; UREA NITROGEN BLOOD LEVEL; URINALYSIS; ANIMAL; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; GENETICS; HUMAN; INJURY; KIDNEY DISEASE; KIDNEY FUNCTION TEST; PATHOLOGY; ROC CURVE; URINE;

ANIMALS; BIOLOGICAL MARKERS; CISPLATIN; CROSS-LINKING REAGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACID-BINDING PROTEINS; HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; MICE; MICE, TRANSGENIC; REPERFUSION INJURY; ROC CURVE;

EID: 65349126356     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.080644     Document Type: Article

References (22)

1. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW: Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005, 16:3365-3370
2. Coca SG, Yalavarthy R, Concato J, Parikh CR: Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int 2008, 73:1008-1016
3. Yamamoto T, Noiri E, Ono Y, Doi K, Negishi K, Kamijo A, Kimura K, Fujita T, Kinukawa T, Taniguchi H, Nakamura K, Goto M, Shinozaki N, Ohshima S, Sugaya T: Renal L-type fatty acid binding protein in acute ischemic injury. J Am Soc Nephrol 2007, 18:2894-2902
4. Portilla D, Dent C, Sugaya T, Nagothu KK, Kundi I, Moore P, Noiri E, Devarajan P: Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery. Kidney Int 2008, 73:465-472
5. Pabla N, Dong Z: Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int 2008, 73:994-1007
6. Doi K, Suzuki Y, Nakao A, Fujita T, Noiri E: Radical scavenger edara- vone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney. Kidney Int 2004, 65:1714-1723
7. McCord JM: Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985, 312:159-163
8. Chen L, Kim SM, Oppermann M, Faulhaber-Walter R, Huang Y, Mizel D, Chen M, Lopez ML, Weinstein LS, Gomez RA, Briggs JP, Schnermann J: Regulation of renin in mice with Cre recombinase-mediated deletion of G protein Gsalpha in juxtaglomerular cells. Am J Physiol 2007, 292:F27-F37
9. Doi K, Leelahavanichkul A, Hu X, Sidransky KL, Zhou H, Qin Y, Eisner C, Schnermann J, Yuen PS, Star RA: Pre-existing renal disease promotes sepsis-induced acute kidney injury and worsens outcome. Kidney Int 2008, 74:1017-1025
10. Noiri E, Peresleni T, Miller F, Goligorsky MS: In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia. J Clin Invest 1996, 97:2377-2383
11. Negishi K, Noiri E, Maeda R, Portilla D, Sugaya T, Fujita T: Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cispla- tin-induced acute kidney injury. Kidney Int 2008, 73:1374-1384
12. Hewitt SM, Dear J, Star RA: Discovery of protein biomarkers for renal diseases. J Am Soc Nephrol 2004, 15:1677-1689
13. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P: Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005, 365:1231-1238
14. Zappitelli M, Washburn KK, Arikan AA, Loftis L, Ma Q, Devarajan P, Parikh CR, Goldstein SL: Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study. Crit Care 2007, 11:R84
15. Wagener G, Jan M, Kim M, Mori K, Barasch JM, Sladen RN, Lee HT: Association between increases in urinary neutrophil gelatinase-asso- ciated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology 2006, 105:485-491
16. Koyner JL, Bennett MR, Worcester EM, Ma Q, Raman J, Jeevanandam V, Kasza KE, O'Connor MF, Konczal DJ, Trevino S, Devarajan P, Murray PT: Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int 2008, 74:1059-1069
17. Parikh CR, Mishra J, Thiessen-Philbrook H, Dursun B, Ma Q, Kelly C, Dent C, Devarajan P, Edelstein CL: Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int 2006, 70:199-203
18. Parikh CR, Abraham E, Ancukiewicz M, Edelstein CL: Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol 2005, 16:3046-3052
19. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A: Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007, 11:R31
20. Han WK, Waikar SS, Johnson A, Betensky RA, Dent CL, Devarajan P, Bonventre JV: Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int 2008, 73:863-869
21. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV: Kidney injury molecule-1 (KIM-1): anovel biomarker for human renal proximal tubule injury. Kidney Int 2002, 62:237-244
22. Dear JW, Kobayashi H, Brechbiel MW, Star RA: Imaging acute renal failure with polyamine dendrimer-based MRI contrast agents. Nephron Clin Pract 2006, 103:c45-c49